[PND62] What Are The Key Drivers for Changing HTA Decisions? Example of Alzheimer’S Disease Treatment in Germany, France and UK
2011 Value in health
Ackermann, J. | Toumi, M. |
Disease, Germany, France,
Since launch, HTA agencies from Germany, France and UK have repeatedly reviewed the use of Alzheimer’s disease (AD) treatments and issued recommendations, which have changed over time. The aim of this study was to understand the drivers of agency decisions and whether these too have changed over time.